The Antitrusting of Patentability
نویسنده
چکیده
Deciding a patent’s validity is costly, and so is deciding it incorrectly. Judges and juries must expend significant resources in order to reach a patent validity determination that is properly informed by the relevant facts. At the same time, patent validity determinations reached quickly and cheaply may conserve resources today while creating future costs. Wrongly preserving an invalid patent can distort the competitive market and enable abuses, such as nuisance litigation. Meanwhile, wrongly striking down a valid patent can undermine incentives for continued investment and commercialization in knowledge assets. Courts facing patent validity issues have begun to strike this balance in favor of conserving resources today—in a manner that is strikingly similar to the per se analysis in antitrust law. A per se rule disposes of supposedly easy cases without engaging in the more fact-intensive “rule of reason” analysis. However, although antitrust jurisprudence cautions against per se rules because of the risk of error and imposes important requirements for the use of per se rules, recent patent jurisprudence has borrowed incautiously from antitrust. This Article explains how the requirements for patentability enable the use of per se analysis, describes how the proper conditions for antitrust per se analysis would translate into patent law, and argues that the current use of antitrust-style judicial shortcuts does not satisfy these conditions in patent law. This Article concludes with a set of proposals for recalibrating the present costs of reaching informed patent validity decisions against the future costs that arise from generating decisions incorrectly.
منابع مشابه
Comparative Study of Patentability of Drug Polymorphism in Iran and the USA
Drug polymorphs are defined as a different arrangement of the same active compounds in crystalline form, which can potentially affect its therapeutic activity by changing the dissolution profile of drug upon administration. Discovery of new polymorphs therefore can provide added value for a previously marketed drug, due to the new advantages provided by the novel polymorph. Therefore, there is ...
متن کاملچالشهای اخلاقی حمایت از روشهای علم پزشکی در حقوق اختراعات
Human inventions and innovations are generally subject to legal protection but some of these innovations are not subject to legal protection. Medical methods are one of the controversial exceptions of patentability of inventions and opponents and proponents of patent ability of medical methods support propound several reasons to prove their theory. While major arguments of proponents are justif...
متن کاملHorizontal inventive step and international protection of intellectual property
Article history: Received 8 December 2011 Received in revised form 6 August 2012 Accepted 7 August 2012 Available online 21 August 2012 This paper studies the intellectual property protection in a global setting where the protection is based on the patentability requirement. When two countries with similar research efficiencies open trade with each other, the world patentability requirement wil...
متن کاملPatentability of Stem Cells in the United States.
Until recently, the patentability of stem cells was well established within the judicial and statutory framework in the United States. However, the shifting landscape of patent law, particularly with regard to patent-eligible subject matter under 35 U.S.C. §101, presents new challenges to the patentability of stem cells. In this paper, we discuss the legal precedent that paved the way for stem ...
متن کاملبررسی سیر تحول در ثبت اختراعات مرتبط با دی.اِن.اِی با تأکید بر رأی دیوان عالی آمریکا در قضیه انجمن پاتولوژی مولکولی علیه شرکت میریاد
Patentability of inventions related to biotechnology and genetics has been one of the most challenging issues in patent law. One of these challenges is whether patenting products in which natural components are used is correct? Can we put human genes in the ownership of certain individuals? In addition, exercising exclusive rights arising from patents will limit the access of people, in particu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2017